Literature DB >> 12459312

DNA methylation, chromatin boundaries, and mechanisms of genomic imprinting.

Félix Recillas-Targa1.   

Abstract

In mammals, the maternal and paternal genomes are both required for normal embryonic and postnatal development. As a consequence, the majority of genes possess a bi-allelic pattern of expression, with the exception of certain loci where transcription is strictly dependent on parental origin. This alternative, termed genomic imprinting, is an epigenetic form of gene regulation that allows controlled expression of one parental allele. Experimental evidence supports the idea that chromatin organization, DNA methylation, replication timing, genomic domain organization, and more recently methylation-dependent boundary function are key components of imprinting mechanisms. Imprinted genes are mainly required during embryogenesis and development, but loss of controlled imprinting has direct consequences in carcinogenesis. For example, imprinted tumor suppressor genes and proto-oncogenes are highly susceptible to allelic inactivation or in contrast to activation that induces tumorigenic processes. Therefore, genomic imprinting represents one of the more challenging and interesting scientific and medical topics, and especially because a large combinatorial set of possibilities for gene regulation arises from the increasing number of imprinted loci identified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459312     DOI: 10.1016/s0188-4409(02)00366-1

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  2 in total

1.  Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF.

Authors:  Philipp Schatz; Dimo Dietrich; Matthias Schuster
Journal:  Nucleic Acids Res       Date:  2004-12-02       Impact factor: 16.971

Review 2.  Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.

Authors:  Felix Recillas-Targa; Inti A De La Rosa-Velázquez; Ernesto Soto-Reyes; Luis Benítez-Bribiesca
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.